In breast cancer [25], especially, knocking down YAP and TAZ increases sensitivity to tamoxifen in MCF7 cells, which suggests that there might be a correlation between YAP/TAZ and hormone receptor signaling. Here, YAP1 is linked to breast carcinoma.